cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue

Journal of Cellular Physiology

Volumn 167, Issue 2, 1996, Pages 213-221

  Papapetropoulos, Andreas ^a   Cziraki, Attila ^a   Rubin, Joseph W ^a   Stone, Christopher D ^a   Catravas, John D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; GUANYLATE CYCLASE; ISOBUTYLMETHYLXANTHINE; MESSENGER RNA; NITROPRUSSIDE SODIUM;

ARTICLE; CATTLE; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FOWL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; PRIORITY JOURNAL; RABBIT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE; SWINE; VASCULAR TISSUE;

ANIMALS; AORTA; ATRIAL NATRIURETIC FACTOR; BASE SEQUENCE; CATTLE; CHICK EMBRYO; CYCLIC GMP; DOGS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GUANYLATE CYCLASE; HUMANS; ISOENZYMES; MICE; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; NITROPRUSSIDE; PEPTIDE FRAGMENTS; PULMONARY ARTERY; PULMONARY VEINS; RABBITS; RATS; RNA, MESSENGER; SAPHENOUS VEIN; SOLUBILITY; SWINE; VASODILATOR AGENTS;

EID: 0029962935     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199605)167:2<213::AID-JCP4>3.0.CO;2-S     Document Type: Article

References (30)

1. Arnal, J.-F., El Amrani, A.-I., and Michel, J.-B. (1993) Atrial natriueretic factor influences in vivo plasma, lung and aortic wall cGMP concentrations differentially. Eur. J. Pharmacol., 273:265-273.
2. Bradford, M. (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72:248-253.
3. Buechler, W.A., Nakane, M., and Murad, F. (1991) Expression of soluble guanylate cyclase activity requires both enzyme subunits. Biochem. Biophys. Res. Commun., 174:351-357.
4. Chhajlani, V., Frandberg, P.-A., Ahlner, J., Axelsson, K.L., and Wikberg, J.E.S. (1991) Heterogeneity in human soluble guanylate cyclase due to alternative splicing. FEBS Lett., 290:157-158.
5. Crawley, D.E., Zhao, L., Giembycz, M.A., Liu, S., Barnes, P.J., Winter, R.J.D., and Evans, T.W. (1992) Chronic hypoxia impairs soluble guanylate cyclase-mediated pulmonary arterial relaxation in the rat. Am. J. Physiol., 263:L325-L332.
6. Draijer, R., Atsma, D.E., van der Laarse, A., and van Hinsbergh, V.W.M. (1995) cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and human umbilical vein endothelial cells. Circ. Res., 76:199-208.
7. Farber, H.W., Antonov, A.S., Romanov, Y.A., Smirnov, V.N., Scarfo, L.M., and Beer, D.J. (1992) Cytokine secretion by human aortic endothelial cells is related to degree of atherosclerosis. Am. J. Physiol., 262:H1088-H1095.
8. Giuili, G., Scholl, U., Bulle F., and Guellaen, G. (1992) Molecular cloning of the cDNAs coding for the two subunits of the soluble guanylyl cyclase from human brain. FEBS Lett., 304:83-88.
9. Harteneck, C., Wedel, B., Koesling, D., Malkewitz, J., Bohme, E., and Schultz, G. (1991) Molecular cloning of a new alpha subunit of soluble guanylate cyclase. Interchangeability of the alpha-subunits of the enzyme. FEBS Lett., 292:217-222.
10. Heller, R., Bussolino, F., Ghigo, D., Garbarino, G., Pescarmona, G., Till., U., and Bosia, A. (1992) Nitrovasodilators inhibitor thrombin-induced platelet-activating factor synthesis in human endothelial cells. Biochem. Pharmacol., 44:223-229.
11. Ignarro, L.J. (1989) Heme-dependent activation of soluble guanylate cyclase by nitric oxide: Regulation of enzyme activity by porhyrins and metalloporhyrins. Semin. Hematol., 26:63-76.
12. Ignarro, L.J., and Kadowitz, P.J. (1985) Pharmacological and physiological role of cGMP in vascular smooth muscle relaxation. Annu. Rev. Pharmacol., 25:171-191.
13. Kim, T.D., and Burstyn, J.N. (1994) Identification and partial purification of an endogenous inhibitor of soluble guanylyl cyclase from bovine lung. J. Biol. Chem., 269:15540-15545.
14. Lewicki, J.A., Brandwein, H.J., Waldman, S.A., and Murad, F. (1980) Purified guanylate cyclase: Characterization, iodination and preparation of monoclonal antibodies. J. Cyclic Nucleotide Res., 6:283-296.
15. Marczin, N., Ryan, U., and Catravas, J.D. (1992) Effects of oxidant stress on endothelium-derived relaxing factor-induced and nitrovasodilator-induced cGMP accumulation in vascular cells in culture. Circ. Res., 70:326-340.
16. Mellion, B.T., Ignarro, L.J., Ohlstein, E.H., Pontecorvo, E.G., Hyman, A.L., and Kadowitz, P.J. (1983) Inhibition of human platelet aggregation by S-nitrosothiols: Heme-dependent activation of soluble guanylate cyclase and stimulation of cGMP accumulation. Mol. Pharmacol., 23:653-664.
17. Münzel, T., Sayegh, H., Freeman, B.A., Tarpey, M.M., and Harrison, D.G. (1995) Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross tolerance. J. Clin. Invest., 95:187-194.
18. Nakane, M., and Murad, F. (1994) Cloning of gyanylyl cyclase isoforms. Adv. Pharmacol., 26:7-18.
19. Nakane, M., Arai, K., Saheki, S., Kuno, T., Buechler, W., and Murad, F. (1990) Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J. Biol. Chem., 265:16841-16845.
20. Newman, W.H., Kato, J., Beckar, B.F., and Currie, M.G. (1992) Difference in effect of atrial natriuretic peptide on cGMP in aortic and coronary smooth muscle cells. Am. J. Physiol., 263:H710-H714.
21. Papapetropoulos, A., Marczin, N., Mora, G., Milici, A., Murad, F., and Catravas, J.D. (1995) Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA and protein levels by cAMP-elevating agents. Hypertension, 26:696-704.
22. Papapetropoulos, A., Marczin, N., Snead, M.D., Cheng, C., Milici, A., and Catravas, J.D. (1994) Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats. Hypertension, 23:476-484.
23. Rapoport, R.M., Waldman, S.A., and Ginsburg, R. (1987) Effects of glyceryltrinitrate on endothelium-dependent and -independent relaxation and cGMP levels in rat aorta and human coronary artery. J. Cardiovasc. Pharmacol., 10:82-89.
24. Schmidt, H.H.H.W., Lohmann, S.M., and Walter U. (1993) The nitric oxide and cGMP signal transduction system: Regulation and mechanisms of action. Biochem. Biophys. Acta, 1178:153-175.
25. Ujiie, K., Drewett, J.G., Yuen, P.S.T., and Star, R.A. (1993) Differential expression of mRNA for guanylyl cyclase-linked endothelium-derived relaxing factor receptor subunits in rat kidney. J. Clin. Invest., 91:730-734.
26. Waldman, S.A., and Murad, F. (1987) cGMP synthesis and function. Pharmacol. Rev., 39:163-196.
27. Westendorp, R.G., Draijer, R., Meinders, A.E., and van Hinsberg, V.W. (1994) Cyclic GMP-mediated decrease in permeability of human umbilical and pulmonary artery endothelial cell monolayers. J. Vasc. Res., 31:42-51.
28. Winquist, R., Faison, E.P., Waldman, S.A., Schwartz, K., Murad, F., and Rapoport, R.M. (1984) Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc. Natl. Acad. Sci. U.S.A., 81:7661-7664.
29. Yuen, P.S.T., Potter, L.R., and Garbers, D.L. (1990) A new form of guanylyl cyclase is preferentially expressed in rat kidney. Biochemistry, 29:10872-10878.
30. Zhang, L.M., Castresana, M.R., Stefansson, S., and Newman, W.H. (1993) Tolerance to sodium nitroprusside. Studies in cultured porcine vascular smooth muscle cells. Anesthesiology, 79:1094-1103.